Medical Devices
January 28, 2009 FDA MDUFMA Performance Report - Quarterly Update on Medical Device Performance Goals - CDRH Performance Data
Actions through December 31, 2008
Data on FY 2003 – FY 2007 Cohorts
PMAs and Panel-Track Supplements
CDRH Actions through December 31, 2008
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| PMAs | 40 | 39 | 41 | 37 | 33 |
| Panel-Track Supplements | 7 | 8 | 11 | 16 | 4 |
| Total Workload | 47 | 47 | 52 | 53 | 37 |
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| FDA Decisions | 47 | 47 | 51 | 50 | 32 |
| Goal – Percent within 320 days |
- | - | - | 80% | 90% |
| Percent of decisions within 320 days | 91.5% | 91.5% | 86.3% | 80.0% | 96.9% |
| Applications without a decision | 0 | 0 | 1 | 3 | 5 |
| Cohort status | Complete | Complete | Open | Open | Open |
| Goal – Percent within 180 days | - | - | - | - | 50% |
| Percent of decisions within 180 days | 44.7% | 36.2% | 31.4% | 36.0% | 62.5% |
PMA and Panel Track PMA Supplements
Percent of CDRH Decisions Meeting 320-day MDUFMA Goal

- Progress to date indicates CDRH will likely meet the goals for FY 2006 and FY 2007.
- The FY 2003 and FY 2004 cohorts are complete. All other cohorts remain open.
Expedited PMAs
CDRH Actions through December 31, 2008
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| Expedited PMAs | 3 | 14 | 6 | 2 | 2 |
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| FDA Decisions | 3 | 13 | 6 | 2 | 1 |
| Goal – Percent within 300 days |
- | - | 70% | 80% | 90% |
| Percent of decisions within 300 days | 100.0% | 92.3% | 83.3% | 50.0% | 0 |
| Applications without a decision | 0 | 1 | 0 | 0 | 1 |
| Cohort Status | Complete | Open | Complete | Open | Open |
Expedited PMAs
Percent of CDRH Decisions meeting MDUFMA Goal

- FY 2003 and FY 2005 cohorts are complete; all other cohorts remain open.
- Because of the small number of Expedited PMAs, a single action may signficantly affect performance measures.
180-day PMA Supplements
CDRH Actions through December 31, 2008
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| 180-day PMA Supplements | 201 | 103 | 99 | 134 | 140 |
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| FDA Decisions | 201 | 103 | 99 | 133 | 139 |
| Goal – Percent within 180 days |
- |
- | 80% | 80% | 90% |
| Percent of decisions within 180 days | 94.0% | 95.1% | 94.9% | 96.2% | 92.1% |
| Applications without a decision | 0 | 0 | 0 | 1 | 1 |
| Cohort Status | Complete | Complete | Complete | Open | Open |
180-day PMA Supplements
Percent of CDRH Decisions Meeting MDUFMA Goal

- FY 2003, FY 2004, and FY 2005 cohorts are complete.
510(k) Premarket Notifications
CDRH Actions through December 31, 2008
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| Received | 4,225 | 3,632 | 3,650 | 3,853 | 3,656 |
| MDUFMA Cohort¹ | 3,741 | 3,309 | 3,344 | 3,446 | 3,168 |
¹ The MDUFMA Cohort excludes 510(k)s that were closed for any reason other than an SE or NSE decision (e.g., when FDA finds that a 510(k) was not required). The number of 510(k)s in the MDUMFA Cohort is subject to change until the cohort is complete.
| FY 2003 | FY 2004 | FY 2005 | FY 2006 | FY 2007 | |
|---|---|---|---|---|---|
| FDA Decisions (SE and NSE) | 3,741 | 3,309 | 3,344 | 3,446 | 3,168 |
| Goal – Percent within 90 days |
- | - | 75% | 75% | 80% |
| Percent of decisions within 90 days | 75.7% | 83.6% | 91.0% | 91.3% | 91.2% |
| Remaining applications | 0 | 0 | 1 | 4 | 26 |
| Cohort Status | Complete | Complete | Open | Open | Open |
510(k) Premarket Notifications
Percent of CDRH Decisions Meeting MDFUMA Goal
Data on FY 2008 – FY 2012 Cohorts
| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Filed to Date) | 33 | 4 | - | - | - |
| Total FDA Decisions | 8 | 0 | - | - | - |
| Percent within Tier 1 goal (180 days) | 100.0% | - | - | - | - |
| Tier 1 goal — Percent within 180 days | 60% | 60% | 60% | 60% | 60% |
| Percent within Tier 2 goal (295 days) | 100.0% | 0.0% | - | - | - |
| Tier 2 goal — Percent within 295 days | 90% | 90% | 90% | 90% | 90% |
| Cohort Status | Open | Open | - | - | - |
PMAs and Panel-track PMA Supplements
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals

| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Filed to Date) | 4 | 0 | - | - | - |
| Total FDA Decisions | 0 | 0 | - | - | - |
| Percent within Tier 1 goal (180 days) | - | - | - | - | - |
| Tier 1 goal — Percent within 180 days | 50% | 50% | 50% | 50% | 50% |
| Percent within Tier 2 goal (280 days) | - | - | - | - | - |
| Tier 2 goal — Percent within 280 days | 90% | 90% | 90% | 90% | 90% |
| Cohort Status | Open | Open | - | - | - |
Expedited PMAs and Expedited Panel-track Supps
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals

| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Filed to Date) | 43 | 15 | - | - | - |
| MDUFMA Cohort | 44 | 15 | - | - | - |
| Total FDA Decisions | 44 | 1 | - | - | - |
| Percent within Tier 1 goal (90 days) | 52.3% | 100.0% | - | - | - |
| Tier 1 goal — Percent within 90 days | 75% | 75% | 75% | 75% | 75% |
| Percent within Tier 2 goal (120 days) | 90.9% | 100.0% | - | - | - |
| Tier 2 goal — Percent within 120 days | 90% | 90% | 90% | 90% | 90% |
| Cohort Status | Open | Open | - | - | - |
PMA Modules
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals

| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Filed to Date) | 168 | 33 | - | - | - |
| Total FDA Decisions | 120 | 3 | - | - | - |
| Percent within Tier 1 goal (180 days) | 96.7% | 100.0% | - | - | - |
| Tier 1 goal — Percent within 180 days | 85% | 85% | 85% | 85% | 85% |
| Percent within Tier 2 goal (210 days) | 99.2% | 100.0% | - | - | - |
| Tier 2 goal — Percent within 210 days | 95% | 95% | 95% | 95% | 95% |
| Cohort Status | Open | Open | - | - | - |
180-Day PMA Supplements
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals

| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Filed to Date) | 248 | 80 | - | - | - |
| Total FDA Decisions | 235 | 44 | - | - | - |
| Percent within Tier 1 goal (60 days) | 96.6% | 100.0% | - | - | - |
| Tier 1 goal — Percent within 60 days | 80% | 80% | 80% | 80% | 80% |
| Percent within Tier 2 goal (90 days) | 99.6% | 100.0% | - | - | - |
| Tier 2 goal — Percent within 90 days | 90% | 90% | 90% | 90% | 90% |
| Cohort Status | Open | Open | - | - | - |
Real-time PMA Supplements
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals

| FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | |
|---|---|---|---|---|---|
| Workload (Received to Date) | 3,851 | 995 | - | - | - |
| MDUFMA Cohort | 2,820 | 159 | - | - | - |
| Total FDA Decisions | 2,830 | 0 | - | - | - |
| Percent within Tier 1 goal (90 days) | 96.4% | - | - | - | - |
| Tier 1 goal — Percent within 90 days | 90% | 90% | 90% | 90% | 90% |
| Percent within Tier 2 goal (150 days) | 99.6% | - | - | - | - |
| Tier 2 goal — Percent within 150 days | 98% | 98% | 98% | 98% | 98% |
| Cohort Status | Open | Open | - | - | - |
510(k) Premarket Notification
Percent of CDRH Decisions Meeting FY 2008 - FY 2012 Goals










